Moderate cervical dysplasia
ICD-10 N87.1 is a billable code used to indicate a diagnosis of moderate cervical dysplasia.
Moderate cervical dysplasia, classified under ICD-10 code N87.1, refers to a precancerous condition of the cervix characterized by abnormal changes in the cervical cells. This condition is typically identified through Pap smear screening and is associated with the presence of human papillomavirus (HPV) infection. Moderate dysplasia indicates that the abnormal cells occupy approximately one-third to two-thirds of the thickness of the cervical epithelium. While moderate dysplasia is not cancer, it is considered a significant risk factor for the development of cervical cancer if left untreated. Regular monitoring and follow-up are essential, and treatment options may include excisional procedures such as LEEP (Loop Electrosurgical Excision Procedure) or cryotherapy. The management of moderate cervical dysplasia often involves collaboration between gynecologists and primary care providers to ensure appropriate follow-up and patient education regarding HPV vaccination and screening guidelines.
Detailed documentation of Pap smear results, HPV testing, and treatment plans.
Routine screening, follow-up of abnormal Pap results, and treatment of dysplasia.
Ensure clear documentation of the severity of dysplasia and any interventions performed.
Documentation of referrals to specialists, patient education on HPV, and follow-up care.
Initial screening referrals, management of HPV vaccination, and monitoring of patients with dysplasia.
Document patient history and any discussions regarding screening and vaccination.
Used for routine screening and diagnosis of cervical dysplasia.
Documentation of the Pap smear results and any follow-up recommendations.
Gynecologists should ensure accurate reporting of findings.
Performed when moderate dysplasia is detected to further evaluate the cervix.
Detailed report of colposcopy findings and any biopsies taken.
Ensure that the procedure is linked to the diagnosis of moderate dysplasia.
Coding N87.1 is crucial for identifying patients at risk for cervical cancer and ensuring they receive appropriate follow-up and treatment.
Patients with moderate cervical dysplasia should be monitored closely, typically every 6 to 12 months, depending on the treatment and follow-up plan established by their healthcare provider.
